Clinical Development Strategy
Scientific and medical input for development plans, study rationale, objectives, endpoints, eligibility criteria, and safety measures.
Clinical development and medical strategy
Independent scientific and clinical expertise for organizations navigating development strategy, trial execution, safety, and medical communication.
Start a conversation Explore servicesAbout the consultant
Dr. Ghazaryan brings together clinical practice, public health, and hands-on clinical development experience.
Her background spans patient care, infectious-disease research, respiratory and upper-airway disease, neuroscience, oncology, rare disease, vaccines, and medical-device development. She has contributed to protocol design, safety assessment, regulatory documentation, study oversight, scientific publication, and collaboration with investigators and key opinion leaders.
MedScience Consulting supports sponsors, research organizations, and health-focused teams that need clear medical judgment, rigorous evidence, and practical execution.
Consulting services
Engagements can be scoped for an individual deliverable, an active study, or broader program support.
Scientific and medical input for development plans, study rationale, objectives, endpoints, eligibility criteria, and safety measures.
Critical review and development of protocols, case report forms, informed consent documents, and study implementation plans.
Country and site feasibility, standards-of-care assessment, investigator engagement, recruitment strategy, and operational problem-solving.
Clinical review of adverse events, causality and severity assessment, signal evaluation, safety monitoring, and data reconciliation.
Medical input and review for INDs, NDAs, BLAs, investigator brochures, clinical study reports, DSURs, PADERs, and PBRERs.
Publication strategy, manuscript and presentation support, evidence interpretation, medical content review, and expert-facing communication.
Therapeutic and functional expertise
Antibacterials, respiratory infections, tuberculosis, HIV, malaria, and emerging infectious-disease programs.
Chronic rhinosinusitis with nasal polyps, asthma, COPD, non-cystic fibrosis bronchiectasis, pneumonia, and ENT conditions.
Clinical development, ongoing safety assessment, signal evaluation, and benefit-risk considerations.
Development strategy and clinical input for Alzheimer disease and selected rare-disease programs.
Clinical and scientific contribution to multidisciplinary development programs and evidence plans.
Program assessment, survey design, monitoring and evaluation, and health initiatives across international settings.
Selected experience
Dr. Ghazaryan’s work includes clinical programs and peer-reviewed research in major medical journals.
Contact
For consulting availability, project scope, or collaboration inquiries, contact MedScience Consulting by email.
MedScience Consulting provides scientific and clinical-development consulting. Website content is for professional informational purposes and is not medical advice or patient-care guidance.